In Vitro and Ex Vivo Evaluation of Polymeric Nanoparticles for Vaginal and Rectal Delivery of the Anti-HIV Drug Dapivirine-Reference-Cited by-同舟云学术

In Vitro and Ex Vivo Evaluation of Polymeric Nanoparticles for Vaginal and Rectal Delivery of the Anti-HIV Drug Dapivirine

Published:2013-06-17 Issue:7 Volume:10 Page:2793-2807
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

das Neves José¹²,Araújo Francisca²³,Andrade Fernanda¹,Michiels Johan⁴,Ariën Kevin K.⁴,Vanham Guido⁴,Amiji Mansoor⁵,Bahia Maria Fernanda¹,Sarmento Bruno¹²³

Affiliation:

1. Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal

2. CICS—Centro de Investigação em Ciências da Saúde, Department of Pharmaceutical Sciences, Instituto Superior de Ciências da Saúde-Norte, Rua Central de Gandra, 1317, 4585-116 Gandra, Portugal

3. INEB—Instituto de Engenharia Biomédica, Rua do Campo Alegre, 823, 4150-180 Porto, Portugal

4. Virology Unit, Department of Microbiology, Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerpen, Belgium

5. Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, 110 Mugar Life Sciences Building, Boston, Massachusetts 02115, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp4002365

Reference65 articles.

1. Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

2. Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana

3. Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women

4. Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women

5. A Randomized Trial to Assess Anti-HIV Activity in Female Genital Tract Secretions and Soluble Mucosal Immunity Following Application of 1% Tenofovir Gel

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and verification of mechanistic vaginal absorption and metabolism model to predict systemic exposure after vaginal ring and gel application;British Journal of Clinical Pharmacology;2024-03-07

2. Synthesis and characterization of tenofovir disoproxil fumarate loaded nanoparticles for HIV‐1 treatment;Nano Select;2024-02-13

3. Cell-based in vitro models for vaginal permeability studies;Concepts and Models for Drug Permeability Studies;2024

4. Tissue-based models for vaginal permeability studies;Concepts and Models for Drug Permeability Studies;2024

5. Hydrogel containing mPEG-PLGA nanoparticles for the vaginal delivery of saquinavir mesylate against HIV infection;European Journal of Pharmaceutical Sciences;2023-12